Notice of Closed Meeting, 47376 [2020-17094]
Download as PDF
<![CDATA[
47376
Federal Register / Vol. 85, No. 151 / Wednesday, August 5, 2020 / Notices
TABLE 2—ESTIMATED ANNUALIZED COST BURDEN
Data collection method or project activity
Number of
respondents
Total burden
hours
Average hourly
rate
Total cost burden
B*C
A.
B.
C.
D.
Key Informant Interviews:
Grantee leadership ...........................................................................
Cooperative leadership .....................................................................
Cooperative partners ........................................................................
Unaffiliated organizations .................................................................
Practices in network not participating in Heart Health QI project ....
Practices in network participating in Heart Health QI project ..........
Member Checking Sessions:
Grantee leadership ...........................................................................
Cooperative leadership .....................................................................
Cooperative partners ........................................................................
Unaffiliated organizations .................................................................
Network practices .............................................................................
Total ...........................................................................................
12
12
24
12
8
20
36
36
60
24
16
28
$110.74
110.74
110.74
110.74
136.49
136.49
$3,986.64
3,986.64
6,644.40
2,657.76
2,183.84
3,821.72
4
4
4
2
12
12
12
6
6
18
110.74
110.74
110.74
110.74
110.74
1,328.88
1,328.88
664.44
664.44
1,993.32
112
254
............................
29,260.96
Note: the rates were based on the mean hourly wages from the Bureau of Labor & Statistics for the closest categories of respondents and
doubled to account for overhead and fringe.
The mean hourly wage rates were
obtained from the Bureau of Labor &
Statistics and doubled to account for
overhead and fringe benefits. The
occupational codes used were as
follows:
• For grantee and cooperative
leadership, partners, and unaffiliated
organizations—medical and health
service managers (11–9111, $53.37)
• For practices—an average of
physicians (29–1228, $97.81), medical
and health services managers (11–9111,
$53.37), and nurse practitioners (29–
1171, $53.77)
jbell on DSKJLSW7X2PROD with NOTICES
Request for Comments
In accordance with the Paperwork
Reduction Act, 44 U.S.C. 3501–3520,
comments on AHRQ’s information
collection are requested with regard to
any of the following: (a) Whether the
proposed collection of information is
necessary for the proper performance of
AHRQ’s health care research and health
care information dissemination
functions, including whether the
information will have practical utility;
(b) the accuracy of AHRQ’s estimate of
burden (including hours and costs) of
the proposed collection(s) of
information; (c) ways to enhance the
quality, utility and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
VerDate Sep<11>2014
16:55 Aug 04, 2020
Jkt 250001
comments will become a matter of
public record.
Dated: July 30, 2020.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2020–17013 Filed 8–4–20; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)-PAR 18–812, NIOSH
Member Conflict.
Date: October 27, 2020.
Time: 1:00 p.m.–5:00 p.m., EDT
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Michael
Goldcamp, Ph.D., Scientific Reviewer Officer,
Office of Extramural Programs, CDC/NIOSH,
1095 Willowdale Road, Morgantown, WV
26506, Telephone: (304) 285–5951,
MGoldcamp@cdc.gov.
The Director, Strategic Business Initiatives
Unit, Office of the Chief Operating Officer,
Centers for Disease Control and Prevention,
has been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–17094 Filed 8–4–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Revised Procedures and Standards:
Home Visiting Evidence of
Effectiveness (HomVEE) Review
Administration for Children
and Families, U.S. Department of Health
and Human Services.
ACTION: Request for public comment.
AGENCY:
The Administration for
Children and Families (ACF), within the
U.S. Department of Health and Human
Services (HHS), oversees the Home
Visiting Evidence of Effectiveness
SUMMARY:
E:\FR\FM\05AUN1.SGM
05AUN1
]]>Agencies
[Federal Register Volume 85, Number 151 (Wednesday, August 5, 2020)]
[Notices]
[Page 47376]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-17094]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention
and Control Special Emphasis Panel (SEP)-PAR 18-812, NIOSH Member
Conflict.
Date: October 27, 2020.
Time: 1:00 p.m.-5:00 p.m., EDT
Place: Teleconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Michael Goldcamp, Ph.D.,
Scientific Reviewer Officer, Office of Extramural Programs, CDC/
NIOSH, 1095 Willowdale Road, Morgantown, WV 26506, Telephone: (304)
285-5951, [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-17094 Filed 8-4-20; 8:45 am]
BILLING CODE 4163-18-P
